PIONEER AF-PCI ( ClinicalTrials.gov NCT01830543 ) is an exploratory , open-label , randomized , multicenter clinical study assessing the safety of 2 rivaroxaban treatment strategies and 1 vitamin K antagonist ( VKA ) treatment strategy in subjects who have paroxysmal , persistent , or permanent nonvalvular AF and have undergone PCI with stent placement .